NasdaqGS:VTRSPharmaceuticals
Viatris Inpefa UAE Launch Puts Valuation Gap And Momentum In Focus
Viatris has launched Inpefa (sotagliflozin) in the United Arab Emirates, its first commercialization of the therapy outside the U.S.
The move marks the beginning of a wider international rollout, with further global expansion planned.
The current Viatris (NasdaqGS:VTRS) share price is $15.74.
For investors watching Viatris, the Inpefa launch in the UAE puts fresh attention on how the company is building out its branded therapy portfolio beyond the U.S. market. The stock is trading at...